All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database

May-17

AUTHORS : Prof Wasim Hanif, University Hospital Birmingham, 5th Floor Nuffield House, Mindelsohn Way, Edgbaston, Birmingham B15 2TH, United Kingdom – Email: Wasim.Hanif@uhb.nhs.uk – Profile: https://www.bcu.ac.uk/nursing-and-midwifery/about-us/staff-directory/wasim-hanif AND also: https://www.bmihealthcare.co.uk/consultants/wasim-hanif

JOURNAL : Journal of Clinical Endocrinology & Metabolism

REFERENCE: 102(5):1719-1725

DOI : 10.1210/jc.2016-3446

All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study